Why the Medicare Specialty Threshold Shouldn’t Drive Pricing Strategy

Explores the considerations that a manufacturer should evaluate when estimating the impact of the specialty threshold in determining pharmaceutical pricing strategy. Also outlines why the specialty threshold should not be a key determinant in most pricing strategies.